What is an aprepitant 40 mg capsule used for?
An aprepitant 40 mg capsule is a prescription medicine used to help prevent nausea and vomiting in people receiving chemotherapy. It works by blocking substance P/neurokinin-1 (NK1) receptors, which are involved in the vomiting reflex.
How is aprepitant 40 mg usually taken?
The typical use depends on the chemotherapy regimen and the presence of other anti-nausea medicines (often a corticosteroid and a 5-HT3 antagonist). Dosing and timing are set by the prescribing clinician and the treatment protocol.
What other strengths are aprepitant capsules available in?
Aprepitant is commonly prescribed in multiple capsule strengths (including 40 mg and other doses) so that prescribers can match dosing to the chemotherapy day schedule.
What side effects are patients most likely to ask about?
Common side effects reported with aprepitant can include fatigue, hiccups, constipation or diarrhea, headache, and dizziness. The full side-effect profile and what is considered urgent can vary by the rest of the antiemetic regimen.
Are there important drug–drug interactions?
Yes. Aprepitant can interact with other medicines because it affects drug-metabolizing enzymes (notably CYP pathways). That means it may change levels of other drugs, including some used for chemotherapy or supportive care. Patients should share a full medication list (including over-the-counter products and supplements) with their prescriber or pharmacist.
What should patients know about safety (pregnancy, breastfeeding, and liver issues)?
Safety considerations depend on the patient’s medical situation and the specific treatment plan. Clinicians typically weigh risks for pregnancy or breastfeeding and may use caution in patients with liver disease or other comorbidities.
How do I find the right information for my exact product?
If you tell me the manufacturer (or the National Drug Code/label details on your bottle), I can help narrow to the correct prescribing information for that specific aprepitant 40 mg capsule.
Sources
No sources were provided in the prompt, and I can’t reliably link to DrugPatentWatch.com without a specific product/patent page or other provided reference details.